Abstract

PurposeSperm play an essential role in embryonic genome activation and embryonic progression to blastocyst. In the present work, we focus on development of embryos created as a result of ICSI with testicular or epididymal sperm from azoospermic males and compare this to outcomes from normospermic males. The objective of this study was to determine if sperm origin influences clinical outcomes, the kinetics of embryo development, or the incidence of cleavage anomalies and multinucleation.MethodsA total of 93 consecutive intracytoplasmic sperm injection cycles (ICSI) performed for 83 couples were included in this study. Observations were made on 594 fertilized oocytes cultured in the EmbryoScope using time-lapse microscopy (TLM). Epididymal sperm (n = 29) cycles or surgically retrieved sperm from the testis (TESE; n = 37 cycles) of men with either obstructive (OA) or non-obstructive azoospermia (NOA) were used to inject oocytes. A further 27 ICSI cycles were performed using ejaculated sperm from normospermic males, designated as our control sperm (CS) group. Kinetic data and cycle outcomes were retrospectively analyzed.ResultsThe clinical pregnancy rate was not different between the three groups (TESE 51.4%, PESA 57.7%, and CS 59.3%). A non-significant decrease was observed in both implantation (30.9%) and live birth rate (43%) with TESE as compared to PESA (35.3%, 58%, respectively) and CS groups (45.1%, 56%, respectively). Failure to compact was significantly higher amongst TESE-NOA embryos (35.2%; P < 0.001) as compared to TESE-OA (4%), PESA (9%), and CS (3.8%) embryos. The two points at which TESE-derived embryos (both NOA and OA) behaved most differently from PESA and CS embryos was at cc2 (t3-t2; time to initiation of the second cell cycle) and tSB (time to start of blastulation). A significantly lower percentage of TESE embryos exhibited kinetics typically ascribed to high quality embryos with the greatest developmental potential. Finally, the incidence of direct uneven cleavage (DUC) was observed to be significantly higher after ICSI with sperm retrieved from azoospermic males.ConclusionsTLM allowed a more in depth comparison of paternal influence on embryo morphokinetics and helped to identify specific differences in cell cycle kinetics. TESE-NOA embryos exhibited a higher incidence of compaction failure.

Highlights

  • One third of couples seeking infertility treatment have male factor as their primary indication

  • A total of 93 consecutive Intracytoplasmic sperm injection (ICSI) cycles performed for 83 couples were included in this study

  • Failure to compact was significantly higher amongst TESE-non-obstructive azoospermia (NOA) embryos (35.2%; P < 0.001) as compared to 4.1% of TESE = OA, 9.0% of percutaneous epididymal sperm aspiration (PESA) and 3.8% of Retrievals Transfers Patient age Oocytes retrieved Mature oocytes Fertilization rate Fertilized oocytes Embryos transferred Clinical pregnancy rate Day 3 transfers Day 5 transfers Implantation rate Day 5 only Live birth rate Miscarriage rate Singleton/multiples

Read more

Summary

Introduction

One third of couples seeking infertility treatment have male factor as their primary indication. Intracytoplasmic sperm injection (ICSI) with sperm surgically retrieved from either the epididymis or testis has dramatically altered the prognosis for successful pregnancy in couples with severe male factor infertility, including azoospermia. The underlying causes of male factor infertility are varied and likely influence the severity of impairment. Specific deletions on the long arm of the Y chromosome, known as the AZF (azoospermia factor) region are clinically important due to their association with failure or disruption of spermatogenesis [1,2,3]. Deletions on the Y chromosome have been associated with 15–20% of cases of azoospermia or severe oligospermia. Other causes of azoospermia include endocrine disruptions, environmental factors, varicoeles, and chemical exposure

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call